Water-based nanoparticulate polymeric system for protein delivery: permeability control and vaccine application.
The idea of using polymeric nanoparticles as drug carriers is receiving an increasing amount of attention both in academia and industry, Nanoparticles have a number of potential applications in protein, drug and vaccine delivery, as well as gene therapy applications. In this article, we focus on this unique drug delivery technology as a method to control the release rate of substances, not only for protein delivery but also for delivering an experimental vaccine immunogen. Nanoparticles were assembled on the basis of ionic interaction between water-soluble polymers so that the resulting particles were stable in physiologic media. Among the typical polymers used to assemble nanoparticles, different polysaccharides, natural amines, and poly-amines were investigated. The entrapped substances tested included a protein and antigens. Polydextran aldehyde was incorporated into the particle core, to enable physiologic cross-linking as a method to control permeability. This resulted in long-term retention of substances that would otherwise rapidly leak out of the nanoparticles. Results of cross-linking experiments clearly demonstrated that the release rate could be substantially reduced, depending on the degree of cross-linking. For vaccine antigen delivery tests, we measured an antibody production after subcutaneous and oral administration. The data indicated that only the cross-linked antigen was immunogenic when the oral route of administration was used. The data presented in this article address primarily the utility of nanoparticulates for oral delivery of vaccine antigen.
Prokop
Ales
A
Chemical Engineering Department, Vanderbilt University, Nashville, Tennessee 37235, USA. ales.prokop@mcmail.vanderbilt.edu
Kozlov
Evgenii
E
Newman
Gale W
GW
Newman
Mark J
MJ
D000284:Administration, Oral; D000818:Animals; D002021:Buffers; D016503:Drug Delivery Systems / Q000379:methods*; D005260:Female; D006863:Hydrogen-Ion Concentration; D051379:Mice; D008810:Mice, Inbred C57BL; D036103:Nanotechnology / Q000379:methods*; D010047:Ovalbumin / Q000008:administration & dosage* / Q000737:chemistry / Q000276:immunology; D010316:Particle Size; D010539:Permeability; D011108:Polymers / Q000008:administration & dosage / Q000737:chemistry*; D015202:Protein Engineering / Q000379:methods; D051381:Rats; D017207:Rats, Sprague-Dawley; D012680:Sensitivity and Specificity; D014612:Vaccines / Q000008:administration & dosage* / Q000737:chemistry / Q000276:immunology; D014867:Water / Q000378:metabolism*
D002021:Buffers; D011108:Polymers; D014612:Vaccines; D014867:Water; D010047:Ovalbumin